FDA approves the first therapy based on RNA interference (RNAi), 10th August 2018

« Back to Previous Page
▲
78
▼
♥ 0

The approved drug, called Patisiran works by silencing the gene that underlies a rare disease called Hereditary Transthyretin Amyloidosis. https://www.nature.com/articles/d41586-018-05867-7

Please to read the entire article.

Marked as spam
Posted by Robert Hewitt (Discussions: 3, Comments: 1)
Replied on August 10, 2018 12:00 am
Category: Pharma & Medical Device Industry
4 views
« Back to Previous Page